Annual progress reports
All eligible countries are invited to submit proposals for Gavi support.
Annual progress report Ghana 2008
Annual progress report Ghana 2007
Annual progress report Ghana 2006
Annual progress report Ghana 2004
Annual progress report Ghana 2005
Annual progress report Ghana 2003
Annual progress report Ghana 2002
Annual progress report Ghana 2001
Annual progress report Ghana 2014
Annual progress report Ghana 2013
Annual progress report Ghana 2012
Annual progress report Ghana 2011
Annual progress report Ghana 2010
Annual progress report Ghana 2009
Proposal for NVS-YF diagnostics 2020 : Ghana
Proposal for CCEOP support (2020-2022): Ghana
Proposal for HSS support 2018 :Ghana
Proposal for NVS- YF campaign 2019 :Ghana
Proposal for NVS 2017 - MR follow-up: Ghana
Proposal for NVS - MenA support 2015: Ghana
Proposal for NVS - MenA support: Ghana(2)
Proposal for Yellow Fever camp, MenA (2015 - 2019) : Ghana
Proposal for NVS - IPV support: Ghana
Proposal for HSS support: Ghana (2014)
Proposal for NVS - MR campaign support: Ghana
Proposal for NVS - HPV demo support: Ghana
Proposal for NVS - PCV, Rota, MSD support: Ghana
Proposal for NVS - MenA campaign support 2012: Ghana
Proposal for CSO support: Ghana
Proposal for ISS support: Ghana
Proposal for HSS support: Ghana
Proposal for INS support: Ghana
Proposal for ISS, NVS - DTP, Hep B, Hib, YF support: Ghana
Proposal for ISS, NVS - YF, Penta support: Ghana
Comprehensive multi-year plans, Financial sustainability plans, National Immunisation Strategy
The comprehensive multi-year plan (cMYP) is a single plan which consolidates several immunisation activities. It is a key planning and management tool for national immunisation programmes. It addresses global, national, and subnational immunisation objectives and strategies, and evaluates the costs and financing of the programme in line with the WHO-UNICEF Global Immunization Vision and Strategy 2006-2015. Gavi requires countries to submit a cMYP along with the standard proposal form when applying for Gavi support (ISS, INS, and NVS). In 2006, over 50 countries had developed cMYPs using the WHO-UNICEF cMYP guidelines and costing tool.
The cMYP replaces the financial sustainability plan (FSP), used to assess the funding challenges of a country's national immunisation programme within the broader health financing context and to describe the government’s approach to mobilising and effectively using resources to support medium- and long-term immunisation objectives.
Country co-financing information sheet
The country-specific co-financing sheets provide up-to-date information on countries’ eligibility status, co-financing fulfilment and requirements. They also give a summary of government health expenditure, including immunisation financing.
Specifically, the sheets provide a history of the Gavi-supported vaccines introduced per country, the country’s co-financing payments to date and its co-financing requirements for the current year. In case the country has defaulted on its co-financing requirements, there is an overview of the co-financing arrears of the previous year. Finally, the sheets provide co-financing projections for the next five years based on our latest forecasts.
The information sheets are updated at least twice per year to account for new information on countries’ co-financing fulfilment (in the first quarter) and eligibility status (in the third quarter).
Co-financing information sheet Ghana
Data quality audit
The DQA has been developed by WHO to help evaluate the quality of countries' health information systems and to verify the accuracy of reported data. Read more.
Decision Letters and Partnerships Agreement
The Decision Letter or Partnership Framework Agreement provides a summary of the details of the new approval or continuation of a Gavi window of support, following the independent review of a new application or annual progress report submitted by a country.
Decision Letter MenA Ghana 2021
Decision Letter YF Ghana 2021
Decision Letter MenA Ghana 2020
Decision Letter RV Ghana 2020
Decision Letter HSS Ghana 2020
Decision Letter YF Ghana 2020
Decision Letter ISD Ghana 2019
Decision Letter MenA Ghana 2019
Decision Letter PCV Ghana 2019
Decision Letter Ghana YF 2019
Decision letter NVS Ghana 2013
Decision Letter Devices Ghana 2018
Decision letter NVS Ghana 2013(2)
Decision Letter NVS Ghana 2018
Decision Letter NVS Ghana 2018 (2)
Decision Letter NVS Ghana 2016 (6)
Decision Letter NVS Ghana 2016 (5)
Decision Letter NVS Ghana 2016 (4)
Decision Letter NVS Ghana 2016 (3)
Ghana Decision Letter Yellow Fever 2019
Decision Letter NVS Ghana 2016
Ghana Decision Letter YF Devices 2019
Decision Letter Ghana HSS 2019
Decision Letter NVS Ghana 2016 (2)
Decision Letter Ghana IPV 2019
Decision Letter NVS Ghana 2015
Decision Letter Ghana ISD 2019
Decision Letter NVS Ghana 2014(2)
Decision Letter Ghana MenA 2019
Decision Letter HSS Ghana 2014
Decision Letter Ghana PCV 2019
Decision Letter NVS Ghana 2014
Decision Letter Ghana Penta 2019
Decision letter CSO Ghana 2014
Decision Letter Ghana Rota 2019
Decision letter NVS Ghana 2013(3)
The HSS evaluation team visited several countries (in depth country studies) and conducted a number of country desk reviews (Country desk studies).
HSS evaluation Ghana
COVAX Technical Assistance Plans
In September 2020, the Gavi Board approved resources from core funding to focus on urgent technical assistance (TA) needs for 92 AMC economies, for the planning and preparation for the introduction of the COVID-19 vaccine. The plan includes sets of activities, milestones and budget for a given year.
COVAX Technical Assistance Plan Ghana 2021
Targeted country assistance plans
Targeted country assistance (TCA) are resources provided to in-country partners under Gavi’s partners’ engagement framework (PEF). A country’s TCA plan is based on needs expressed by the country during the joint appraisal discussions. It includes sets of activities, milestones and budget for a given year.
The joint appraisal report and Multi-Stakeholder Dialogue
The joint appraisal is an in-country, multi-stakeholder review of the implementation progress and performance of Gavi's vaccine and cash grant support to the country, and of its contribution to improved immunisation outcomes. The outcome of the appraisal is the completed "joint appraisal report" that captures Gavi grant performance as well as implementation challenges. The joint appraisal report informs discussions with national coordination mechanisms on areas where greater national investments and efforts, as well as technical support, are needed.
In 2020/2021, as a result of the COVID-19 pandemic, Multi-stakeholder dialogue (MSD) documents temporarily replaced the traditional Joint Appraisal to ensure that Gavi’s continuing support to the EPI programme be aligned with realities at country level.